From: Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients
Factors | Relative risk | Test for homogeneity |
---|---|---|
Cochlea mean dose (Gy) | Â | p = 0.21 |
> 50 | 2.1 (95% CI 0.62-7.15) | Â |
≤ 50 | 0.63 (95% CI 0.15-2.67) |  |
Inner ear mean dose (Gy) | Â | p = 0.14 |
> 45 | 3.06 (95% CI 0.51-18.33) | Â |
≤ 45 | 0.67 (95%CI 0.2-2.19) |  |
IAC mean dose (Gy) | Â | p = 0.89 |
> 50 | 1.33 (95% CI 0.47-3.78) | Â |
≤ 50 | 1.18 (95% CI 0.29-4.81) |  |